Literature DB >> 22439755

Apoptosis in Buruli ulcer: a clinicopathological study of 45 cases.

Elisa Zavattaro1, Francesca Boccafoschi, Cinzia Borgogna, Alessandro Conca, Roch Christian Johnson, Ghislain Emmanuel Sopoh, Ange Dodji Dossou, Enrico Colombo, Claudio Clemente, Giorgio Leigheb, Guido Valente.   

Abstract

AIMS: To investigate the presence and pathogenetic role of apoptosis in Buruli ulcer (BU), a highly destructive skin disease caused by Mycobacterium ulcerans. METHODS AND
RESULTS: Forty-five skin biopsies obtained from 30 Beninese patients affected by BU, in different clinical and therapeutic periods, were analysed for the main histopathological features (inflammatory infiltration, necrosis, sclerosis, oedema, granulomas and nerve damage). Immunofluorescent detection of antigens (anti-Bax, anti-caspases-3 and -8), together with deoxyuridine, 5'-triphosphate (dUTP) nick end labelling (TUNEL) assay, were also performed. A significant decrease in inflammatory infiltration (P = 0.0001) was detected between the beginning and end of antibiotic treatment. Neutrophils predominated in the first phase, while lymphocytes and plasma cells were increased at the end of the therapy. An inverse correlation between tissue necrosis and sclerosis was observed (P = 0.001). In 11 cases, inflammatory and regressive changes involved the nerve bundles with axonal degeneration and disruption of nerve fibres. TUNEL assay detected apoptotic bodies within nerve bundles, and these decreased from beginning to end of therapy. Bax, caspase-3 and -8 were down-regulated over the course of antibiotic therapy.
CONCLUSIONS: In BU, apoptosis plays a role in promoting and sustaining the destructive changes and is implicated in the neural pathology that is associated with clinically detected anaesthesia.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22439755     DOI: 10.1111/j.1365-2559.2012.04206.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  6 in total

1.  Mycolactone-Dependent Depletion of Endothelial Cell Thrombomodulin Is Strongly Associated with Fibrin Deposition in Buruli Ulcer Lesions.

Authors:  Joy Ogbechi; Marie-Thérèse Ruf; Belinda S Hall; Katherine Bodman-Smith; Moritz Vogel; Hua-Lin Wu; Alexander Stainer; Charles T Esmon; Josefin Ahnström; Gerd Pluschke; Rachel E Simmonds
Journal:  PLoS Pathog       Date:  2015-07-16       Impact factor: 6.823

2.  Pain Associated with Wound Care Treatment among Buruli Ulcer Patients from Ghana and Benin.

Authors:  Marike Alferink; Janine de Zeeuw; Ghislain Sopoh; Chantal Agossadou; Karibu M Abass; Richard O Phillips; Susanne Loth; Emma Jutten; Yves T Barogui; Roy E Stewart; Tjip S van der Werf; Ymkje Stienstra; Adelita V Ranchor
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

3.  Mycolactone-mediated neurite degeneration and functional effects in cultured human and rat DRG neurons: Mechanisms underlying hypoalgesia in Buruli ulcer.

Authors:  U Anand; M Sinisi; M Fox; A MacQuillan; T Quick; Y Korchev; C Bountra; T McCarthy; P Anand
Journal:  Mol Pain       Date:  2016-06-20       Impact factor: 3.395

4.  Mycolactone cytotoxicity in Schwann cells could explain nerve damage in Buruli ulcer.

Authors:  Junichiro En; Sho Kitamoto; Akira Kawashima; Suguru Yonezawa; Yoshito Kishi; Norihisa Ishii; Masamichi Goto
Journal:  PLoS Negl Trop Dis       Date:  2017-08-04

5.  Mycolactone displays anti-inflammatory effects on the nervous system.

Authors:  Caroline Isaac; Annie Mauborgne; Alfonso Grimaldi; Kemy Ade; Michel Pohl; Cristina Limatola; Yves Boucher; Caroline Demangel; Laure Guenin-Macé
Journal:  PLoS Negl Trop Dis       Date:  2017-11-17

6.  Aberrant stromal tissue factor localisation and mycolactone-driven vascular dysfunction, exacerbated by IL-1β, are linked to fibrin formation in Buruli ulcer lesions.

Authors:  Louise Tzung-Harn Hsieh; Scott J Dos Santos; Belinda S Hall; Joy Ogbechi; Aloysius D Loglo; Francisco Javier Salguero; Marie-Thérèse Ruf; Gerd Pluschke; Rachel E Simmonds
Journal:  PLoS Pathog       Date:  2022-01-31       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.